Background
==========

The stable atherosclerotic cardiovascular plaque is the most common cardiac disease \[[@b1-medscimonit-24-3265]\]. Currently available techniques for detection of cardiac plaques are: pathological findings such as measurement of serum immunoglobulin 4 (IgG4) \[[@b2-medscimonit-24-3265]\], alanine aminotransferase, aspartate aminotransferase, and bilirubin \[[@b3-medscimonit-24-3265]\]. However, the pathology exam fails to evaluate the morphology of plaques \[[@b4-medscimonit-24-3265]\]. Moreover, thermography \[[@b5-medscimonit-24-3265]\], intravascular magnetic resonance \[[@b6-medscimonit-24-3265]\], intravascular ultrasound \[[@b7-medscimonit-24-3265]\], retrograde coronary sinus angiography \[[@b8-medscimonit-24-3265],[@b9-medscimonit-24-3265]\], arterial phase coronary sinus angiography \[[@b10-medscimonit-24-3265]\], and electron beam CT (computed tomography) \[[@b11-medscimonit-24-3265]\] are also available for diagnosis. At present, cardiac resynchronization therapy is an important treatment for heart failure patients \[[@b12-medscimonit-24-3265],[@b13-medscimonit-24-3265]\].

Retrograde cardiac arteriography is considered the criterion standard for studying cardiac arterial system anatomy. However, the procedure is complicated, congested, and does not fully succeed in outlining the anatomy of the cardiac arterial system \[[@b14-medscimonit-24-3265]\]. Recent developments in diagnostic technology such as multi-slice CT have successfully shown the evolution of morphology of cardiac plaques \[[@b15-medscimonit-24-3265]\] and have provided a three-dimensional view of the cardiovascular system \[[@b16-medscimonit-24-3265]\]. Coronary CT angiography has allowed quantification, partial characterization, and detection of stable atherosclerotic plaques\[[@b17-medscimonit-24-3265]\].

The objective of the present study was to assess differences in coronary sinus diameter between patients in and not in stable atherosclerotic plaque(s) using 256-slice coronary CT angiography in a Chinese population.

Material and Methods
====================

Material
--------

Metoprolol was purchased from Astrazeneca, Taizhou, Jiangsu, China. The contrast agent (Ioversol Injection) was purchased from Jiangsu Hengrui Medicine Co., Ltd., Jiangsu, China.

Ethics approval and consent to participate
------------------------------------------

An exemption was granted to the requirement to register the study with the Chinese Clinical Registry by the Central Research Radiological Society of China. The protocol of the study followed STARD 2015 guidelines and the Helsinki Declaration, and was approved by the Ethics Committee of Beijing Luhe Hospital, Capital Medical University, China for radiological research on human subjects. The study was carried out in compliance with the laws of P.R. China. Written informed consent was obtained from all enrolled patients. All subjects signed an informed consent form approved by the Ethics Committee of Beijing Luhe Hospital, Capital Medical University, China for publication in all formats irrespective of time and language. Data were accessed from patients' DCOIM files of Beijing Luhe Hospital, Beijing, China.

Inclusion criteria
------------------

A total of 336 patients older who were 18 years and who were admitted to the Beijing Luhe Hospital, China for treatment of cardiac abnormalities from June 2014 to February 2017 were included in the study. Patients were allocated into 2 groups of 168 patients each. Patients who had heart failure were included in the study group and those who did not have heart failure were included in the non-study group. Patients with stable angina were included in the study group. Patients who had coronary artery diseases, abnormality of the electrocardiogram, or multiple cardiovascular risks(s) quantified by pathology were included in the study group. Patients who had systolic heart failure, reduced ejection fraction, diastolic heart failure, or high left ventricle filling pressures with normal or near-normal ejection fraction characterized by electrocardiogram were included in the study group. Demographic and angiographic parameters of included subjects are reported in [Table 1](#t1-medscimonit-24-3265){ref-type="table"}.

Exclusion criteria
------------------

Patients who had a previous history of coronary artery interventions, bypass, or graft surgeries were excluded from the study group and non-study group. Patients who had inadequate image quality and ethical issues such as not signing the informed consent form or did not follow protocols were excluded from the study group and non-study group. Patients who had variant angina were excluded from the study group. Patients who had cardiac abnormalities were excluded from the non-study group.

Both groups were subjected to the non-randomized, non-experimental, cross-sectional study. The flowchart of research for patients enrolled in the study group is reported in [Figure 1](#f1-medscimonit-24-3265){ref-type="fig"}.

Coronary CT angiography method
------------------------------

Cardiovascular images were performed with 256-slice coronary CT angiography (Brilliance iCT, Philips, Cleveland, OH) with a prospective electrocardiogram. The instrument was operated at parameters of 120 kVp tube voltage, 900 mAs product of effective tube current-time, 0.18 pitch, and the detector had 128×0.625 mm configuration and rotation time of 270 ms. Heart rate was maintained at 70 beats/min by Metoprolol before coronary CT angiography. The Agent Ioversol was given in 3 distinct phases as 25 ml (saline), 70--85 ml (contrast agent), 20 ml (saline), and at 5 ml/s \[[@b8-medscimonit-24-3265]\]. The high pressure injector HSCPF (Ulrich, GmbH&Co, KG, Germany) was used for the ascending aorta to mark a region of interest (ROI) for the study. The ROI was focused on the chosen area of the coronary artery \[[@b18-medscimonit-24-3265]\]. For aorto-pulmonary fenestration level, the scans were started 5 s after the attenuation of the signal at 130 HU (Hounsfield units) threshold \[[@b19-medscimonit-24-3265]\]. Volume-rendered reconstructions was adopted for evaluation of anterior vein of inter-ventricle, posterior left ventricular vein, posterior vein of inter-ventricle, and the left vein of margin. In the crux cordis area, the angle that makes the coronary sinus to the right atrium is considered as 'ostium'. The diameter of the ostium of the coronary sinus in superoinferior and anteroposterior sides was detected by multiplanar reformatting. The initial diameter of the tributary was measured. The axial images were measured by the ostium. The length of tributaries, the ostium-to-tributaries distance, and the angle between the coronary sinus and the tributaries were measured \[[@b20-medscimonit-24-3265]\]. The diameter of the plaque was calculated as the ratio of the smallest diameter of the lumen to the lumen diameter of the reference. Obstructive atherosclerotic cardiovascular disease was considered to be present if the contrast-enhanced lumen was narrowed to less than 50%. Symptoms and pathological finding of enrolled patients were also recorded.

Statistical analysis
--------------------

The 2-tailed paired *t* test (α=0.01 and β=0.1 for both tails) \[[@b21-medscimonit-24-3265]\] following Dunnett's multiple comparison tests (considering critical value \[*q*\] \>4.145 as significant) \[[@b22-medscimonit-24-3265]\] was performed for demographical and angiographical characteristics, the quantitative measurement of 256-slice coronary CT, and clinical manifestation. The Mann-Whitney *U* test \[[@b23-medscimonit-24-3265]\] following Dunnett's multiple comparison tests (considering *q*\>4.145 as a significant level) \[[@b22-medscimonit-24-3265]\] was performed to show that hypertension, dyslipidemia, and diabetes had higher chances of stable angina in study group patients. The statistical analysis was performed using InStat, GraphPad, Inc., US. The results were considered significant at 99% of the confidence level.

Results
=======

Clinical electrocardiogram, the estimated glomerular filtration rate, blood cholesterol levels, and the other clinical data of study group patients indicated a stable atherosclerotic plaque in the study group subjects ([Table 2](#t2-medscimonit-24-3265){ref-type="table"}).

The diameters of the superoinferior coronary sinus ostium was larger as compared to the anteroposterior coronary sinus ostium ([Figure 2](#f2-medscimonit-24-3265){ref-type="fig"}, *p*\<0.0001, *q*=26.325). There was a difference in size of the coronary sinus ostium between patients in and not in stable atherosclerotic plaque (*p*\<0.0001). The angle for the coronary sinus to the tributaries were the same between groups. The quantitative measurement of 256-slice coronary CT is reported in [Table 3](#t3-medscimonit-24-3265){ref-type="table"}.

Percentage prevalence of arterial plaque characteristics showed that hypertension ([Figure 3](#f3-medscimonit-24-3265){ref-type="fig"}, *p*=0.0041, *q*=5.471), dyslipidemia ([Figure 4](#f4-medscimonit-24-3265){ref-type="fig"}, *p*=0.0045, *q*=4.982), and diabetes ([Figure 5](#f5-medscimonit-24-3265){ref-type="fig"}, *p*=0.0038, *q*=5.876) had higher chances of stable angina in study group patients. Clinical manifestation of study group patients did not clearly show cardiac abnormality ([Table 4](#t4-medscimonit-24-3265){ref-type="table"}).

Discussion
==========

The present study compared quantitative coronary characteristics of study group patients to non-study group patients using 256-slice coronary CT angiography with a prospective electrocardiogram. At present, studies are available with 4-slice \[[@b24-medscimonit-24-3265]\], 16-slice \[[@b8-medscimonit-24-3265],[@b15-medscimonit-24-3265]\], 64-slice \[[@b25-medscimonit-24-3265],[@b26-medscimonit-24-3265]\], 128-slice CT \[[@b27-medscimonit-24-3265]\], and 320-slice \[[@b28-medscimonit-24-3265]\] coronary CT angiography with a prospective electrocardiogram to compare quantitative coronary characteristics. Four-slice CT gives comparatively poor image quality \[[@b29-medscimonit-24-3265]\], 256-slice CT gives more stable and significantly improved image quality at the same effective radiation dose as 16-slice, 64-slice, and 128-slice CT \[[@b26-medscimonit-24-3265]\], but 320-slice CT has a risk of development of radiation-induced malignancy \[[@b30-medscimonit-24-3265]\]. With reference to the latest generation multi-slice CT, the method used in the study had reduced scanning time, breath-holding time, and dose of radiation.

There were 2 major findings of the current study. First, the angle of the coronary sinus ostium was greater in study group patients than in non-study group patients. Second, ostium diameter of tributaries was significantly larger in study group patients than in non-study group patients. Previous studies have shown that contrast-enhanced whole-heart coronary arteries have normal and variant anatomy \[[@b31-medscimonit-24-3265]\]. In respect to the method used (CT), the result was superior to non-invasive evaluation technique.

The 256-slice coronary CT angiography with a prospective electrocardiogram is non-invasive, has higher imaging success rate, faster rotation time, and larger detector coverage. Cardiac arteriography is considered the criterion standard, but is invasive, technically complicated, risks coronary sinus trauma, has longer breath-holding time, and requires a much higher volume of contrast agent \[[@b32-medscimonit-24-3265]\]. Magnetic resonance angiography (MRA) is also non-invasive and does not require contrast material \[[@b14-medscimonit-24-3265]\]. However, MRA has high scan time and low spatial resolution \[[@b19-medscimonit-24-3265]\]. IgG4 \[[@b33-medscimonit-24-3265]\], alanine aminotransferase, aspartate aminotransferase, and bilirubin activation be involved in cardiovascular diseases. However, it is not clear that patients with stable atherosclerotic plaque(s) have always higher IgG4 \[[@b2-medscimonit-24-3265]\], alanine aminotransferase, aspartate aminotransferase, and bilirubin \[[@b3-medscimonit-24-3265]\] levels than normal patients. In relation to the method used, the present study provided good guidance regarding diagnosis modality implantation.

The 256-slice coronary CT angiography with a prospective electrocardiogram provides a better visualization of coronary sinus angiography with no effect of contrast agent on patients after radiotherapy. Retrograde coronary sinus angiography does not detect all left posterior and marginal veins \[[@b8-medscimonit-24-3265]\]. Small cardiac veins that directly drain into the atrium are not detected by retrograde coronary sinus angiography \[[@b34-medscimonit-24-3265]\]. In respect to the method of the study, the findings provided a better overview, which is necessary for detection of stable atherosclerotic cardiovascular disease.

Percentage prevalence of arterial plaque characteristics showed that hypertension, dyslipidemia, and diabetes had higher chances of stable angina in study group patients. These data were in line with results of another available study \[[@b1-medscimonit-24-3265]\].

Certain limitations of the study need to be mentioned. We failed to examine all segments of the heart. Such results are debatable for the variant atherosclerotic cardiovascular plaque. Suboptimal images were obtained. The radiation dose was comparatively high. The study was not compared to data obtained using the criterion standard technique. A specific setting for patient BMI was not used. Use of 256-slice coronary CT angiography with a prospective electrocardiogram is obsolete. Therefore, further study is required using newer-generation CT. Finally, the rate of contrast administration was very low.

Conclusions
===========

We found that 256-slice coronary computed tomographic angiography is a non-invasive bio-tool for evaluation of coronary artery anatomy, and it has diagnostic applications such as predicting stable atherosclerotic cardiovascular disease.
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![Flowchart of the non-randomized, non-experimental, and cross-sectional study of the enrolled patients.](medscimonit-24-3265-g001){#f1-medscimonit-24-3265}

![Coronary sinus diameter of study group patient. (**A**) Coronary sinus ostium, superoinferior, ø: 0.99±0.14 cm. (**B**) Coronary sinus ostium, anteroposterior, ø: 0.66±0.1 cm. ø: diameter. The diameters of coronary sinus ostium, superoinferior was larger as compared to coronary sinus ostium, anteroposterior (*p*\<0.0001, *q*=26.325). The Mann-Whitney *U* test following Dunnett's multiple comparison tests was used for statistical analysis. A *p*\<0.01 and *q*\>4.145 were considered as significant.](medscimonit-24-3265-g002){#f2-medscimonit-24-3265}

![Percentage prevalence of arterial plaque characteristics for hypertension in study group subjects. Data are represented as mean ±SD. n=168. Hypertension had higher chances of stable angina (*p*=0.0041, *q*=5.471). The Mann-Whitney *U* test following Dunnett's multiple comparison tests was used for statistical analysis. A*p*\<0.01 and *q*\>4.145 were considered as significant.](medscimonit-24-3265-g003){#f3-medscimonit-24-3265}

![Percentage prevalence of arterial plaque characteristics for dyslipidemia in study group subjects. Data are represented as mean ±SD. n=168. Dyslipidemia had higher chances of stable angina (*p*=0.0045, *q*=4.982). The Mann-Whitney *U* test following Dunnett's multiple comparison tests was used for statistical analysis. A*p*\<0.01 and *q*\>4.145 were considered as significant.](medscimonit-24-3265-g004){#f4-medscimonit-24-3265}

![Percentage prevalence of arterial plaque characteristics for diabetes in study group subjects. Data are represented as mean ±SD. n=168. Diabetes had higher chances of stable angina (*p*=0.0038, *q*=5.876). The Mann-Whitney *U* test following Dunnett's multiple comparison tests was used for statistical analysis. A*p*\<0.01 and *q*\>4.145 were considered as significant.](medscimonit-24-3265-g005){#f5-medscimonit-24-3265}

###### 

Demographical and angiographical parameters of subjects.

  Characters             Study group (n=168)   Non-study group (n=168)   Multivariate analysis                                                                
  ---------------------- --------------------- ------------------------- ----------------------- ------------------------------------------------------------ -----------------------------------------------------------
  Gender                 Male                  92 (55)                   89 (53)                 0.0833                                                       N/A
  Female                 76 (45)               79 (47)                                                                                                        
  Age (years)            50.71±9               50.47±7.86                0.8004                  N/A                                                          
  BMI(kg/m^2^)           30.04±3.74            29.76±3.14                0.4745                  N/A                                                          
  Heart rate (bpm)       62.7±3.28             61.93±2.85                0.0243                  N/A                                                          
  Hypertension           89 (53)               5 (3)                     \<0.0001                14.286[\*](#tfn2-medscimonit-24-3265){ref-type="table-fn"}   
  Dyslipidemia           88 (52)               7 (4)                     \<0.0001                13.298[\*](#tfn2-medscimonit-24-3265){ref-type="table-fn"}   
  Diabetes               73 (43)               15 (9)                    \<0.0001                8.551[\*](#tfn2-medscimonit-24-3265){ref-type="table-fn"}    
  Smoking status         Current smoker        30 (18)                   7 (4)                   \<0.0001                                                     6.881[\*](#tfn2-medscimonit-24-3265){ref-type="table-fn"}
  Former smoker          40 (24)               12 (7)                                                                                                         
  No smoker              98 (58)               149 (89)                                                                                                       
  Psychological stress   47 (28)               7 (4)                     \<0.0001                7.104[\*](#tfn2-medscimonit-24-3265){ref-type="table-fn"}    
  Alcohol intake         26 (15)               3 (2)                     \<0.0001                5.32[\*](#tfn2-medscimonit-24-3265){ref-type="table-fn"}     

Categorical data were presented as Number (Percentage) and continuous data were presented as a mean ±SD. Two-tailed paired *t*-test following Dunnett's multiple comparison tests was used for statistical analysis. A*p*\<0.01 and *q*\>4.145 were considered as significant. N/A -- not applicable.

Significant difference.

###### 

Clinical electrocardiogram, the estimated glomerular filtration rate, blood cholesterol levels of subjects.

  Characters                        Study group (n=168)     Non-study group (n=168)   Multivariate analysis                                                                
  --------------------------------- ----------------------- ------------------------- ----------------------- ------------------------------------------------------------ ------------------------------------------------------------
  eGFR (mL/min/1.73 m^2^)           67.89±4.37              72.64±4.59                \<0.0001                9.636[\*](#tfn4-medscimonit-24-3265){ref-type="table-fn"}    
  LDL (mg/dL)                       110.02±3.15             102.5±2.3                 \<0.0001                26.364[\*](#tfn4-medscimonit-24-3265){ref-type="table-fn"}   
  HDL (mg/dL)                       58.96±6.32              63.63±7.13                \<0.0001                6.23[\*](#tfn4-medscimonit-24-3265){ref-type="table-fn"}     
  Triglyceride (mg/dL)              118.93±21.25            115.21±25.09              0.1182                  N/A                                                          
  IgG4 (mg/dL)                      37.5±12.16              31.82±12.65               \<0.0001                4.168[\*](#tfn4-medscimonit-24-3265){ref-type="table-fn"}    
  Epicardial fat volume (mL)        108.07±17.47            83.46±12.25               \<0.0001                15.889[\*](#tfn4-medscimonit-24-3265){ref-type="table-fn"}   
  Conditions of electrocardiogram   ST-segment depression   33 (20)                   2 (1)                   \<0.0001                                                     18.989[\*](#tfn4-medscimonit-24-3265){ref-type="table-fn"}
  ST-segment elevation              31 (18)                 2 (1)                                                                                                          
  T-wave inversion                  29 (17)                 2 (1)                                                                                                          
  Flattening of T-waves             22 (13)                 2 (1)                                                                                                          
  Large Q-wave                      26 (15)                 2 (1)                                                                                                          
  Reduced R-wave                    17 (10)                 2 (1)                                                                                                          
  Normal                            10 (7)                  156 (94)                                                                                                       

Categorical data were presented as Number (Percentage) and continuous data were presented as a mean ±SD. eGFR -- estimated glomerular filtration rate; LDL -- low-density lipoprotein; HDL -- high-density lipoprotein; IgG4 -- Immunoglobulin G4. Two-tailed paired *t*-test following Dunnett's multiple comparison tests was used for statistical analysis. A*p*\<0.01 and *q*\>4.145 were considered as significant. N/A -- not applicable.

Significant difference.

###### 

Quantitative measurement Coronary computed tomographic angiography method.

  Characters                                         Study group (n=168)                      Non-study group (n=168)   p Value       q Value                                                     
  -------------------------------------------------- ---------------------------------------- ------------------------- ------------- ----------------------------------------------------------- ----------------------------------------------------------
  Diameter (cm)                                      Coronary sinus ostium, anteroposterior   0.82±0.07                 0.66±0.1      \<0.0001                                                    16.475
  Coronary sinus ostium, superoinferior              1.08±0.13                                0.99±0.14                 \<0.0001      5.581                                                       
  PVIV                                               0.66±0.1                                 0.5±0.13                  \<0.0001      12.568                                                      
  PLVV                                               0.49±0.06                                0.31±0.05                 \<0.0001      28.783                                                      
  LVM                                                0.47±0.05                                0.29±0.04                 \<0.0001      41.782                                                      
  AVIV                                               0.5±0.07                                 0.33±0.04                 \<0.0001      27.257                                                      
  θ of the coronary sinus ostium (°)                 68.86±5.43                               60.91±4.87                \<0.0001      14.131                                                      
  Length (cm)                                        PVIV                                     3.67±0.47                 3.33±0.45     \<0.0001                                                    6.471
  PLVV                                               2.68±0.41                                2.31±0.45                 \<0.0001      6.123                                                       
  LVM                                                2.42±0.49                                2.25±0.44                 \<0.0001      3.287[\*](#tfn6-medscimonit-24-3265){ref-type="table-fn"}   
  AVIV                                               4.5±0.5                                  4.25±0.43                 0.0001        4.892                                                       
  The ostium to tributaries distance                 PVIV                                     0.48±0.04                 0.42±0.04     \<0.0001                                                    10.923
  PLVV                                               3.25±0.43                                3.125±0.33                \<0.0001      2.969[\*](#tfn6-medscimonit-24-3265){ref-type="table-fn"}   
  LVM                                                6.76±0.43                                6.63±0.48                 0.0049        2.633[\*](#tfn6-medscimonit-24-3265){ref-type="table-fn"}   
  AVIV                                               10.1±0.29                                9.8±0.4                   \<0.0001      7.653                                                       
  θ between coronary sinus and the tributaries (°)   PVIV                                     86.45±13.45               83.44±12.06   0.0292                                                      2.16[\*](#tfn6-medscimonit-24-3265){ref-type="table-fn"}
  PLVV                                               109.61±13.92                             105.54±12.22              0.0008        2.862[\*](#tfn6-medscimonit-24-3265){ref-type="table-fn"}   
  LVM                                                121.64±17.88                             119.66±16.48              0.1463        1.06[\*](#tfn6-medscimonit-24-3265){ref-type="table-fn"}    
  AVIV                                               130.42±9.91                              134.04±11.46              0.0022        3.101[\*](#tfn6-medscimonit-24-3265){ref-type="table-fn"}   

PVIV -- posterior vein of internal ventricle; PLVV -- posterior left ventricular vein; LVM -- left vein of margin; AVIV -- anterior vein of internal ventricle; θ -- angle. Data were represented as mean ±SD. The Mann-Whitney *U* test following Dunnett's multiple comparison tests was used for statistical analysis. *p*\<0.01 and *q*\>4.145 were considered as significant.

Insignificant value.

###### 

Clinical manifestation of the enrolled patients.

  Characters                                           Study group (n=168)   Non-study group (n=168)   p Value    q Value
  ---------------------------------------------------- --------------------- ------------------------- ---------- -----------------------------------------------------------
  Chest tightness                                      45 (27)               3 (2)                     \<0.0001   7.01
  Suspected Cardiological abnormal                     105 (63)              7 (4)                     \<0.0001   14.436
  Abnormal lipid profile                               69 (41)               8 (5)                     \<0.0001   8.799
  Weight loss                                          8 (5)                 2 (1)                     0.0139     1.937[\*](#tfn8-medscimonit-24-3265){ref-type="table-fn"}
  Chest pain                                           22 (13)               6 (4)                     \<0.0001   3.282[\*](#tfn8-medscimonit-24-3265){ref-type="table-fn"}
  Chest muscles cramps                                 11 (7)                1 (1)                     0.0014     3.005[\*](#tfn8-medscimonit-24-3265){ref-type="table-fn"}
  Physicians opinion referred for radiology            145 (86)              39 (23)                   \<0.0001   19.245
  Fatigue                                              56 (33)               23 (14)                   \<0.0001   4.549
  Restlessness                                         41 (24)               3 (2)                     \<0.0001   6.571
  Abnormal serum level of alanine aminotransferase     49 (29)               2 (1)                     \<0.0001   7.817
  Abnormal serum level of aspartate aminotransferase   63 (38)               3 (2)                     \<0.0001   11.763

Data were represented as a number (percentage). For statistical analysis, the presence of clinical symptom was considered as 1 and absence were considered as 0. The Mann-Whitney *U* test following Dunnett's multiple comparison tests was used for statistical analysis. A*p*\<0.01 and *q*\>4.145 were considered as significant.

Insignificant value.
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